With nearly 78,000 cases and more than 2,300 deaths from the novel coronavirus, Harvard University scientists will join forces with colleagues from China to improve diagnostics, develop vaccines to prevent new infections, and antiviral therapies to treat existing ones.

A decline in cancer mortality was a prominent feature of recent good news about U.S. life expectancy. The Gazette spoke with the director of the Chan School’s Zhu Family Center for Global Cancer Prevention to understand why.

Artificial intelligence researchers and neurobiologists share data on how options are sorted in decision-making.

Taxes on sugary drinks are potentially effective tools to fight the obesity epidemic and advocates are drawing lessons from the long battle against tobacco as they plot what they know will be a tough road ahead.

Professor Emily Balskus and her team have identified an entirely new class of enzymes that degrade chemicals essential for neurological health, but also help digest foods like nuts, berries, and tea, releasing nutrients that may impact human health.

Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.

Harvard’s Marc Lipsitch said evidence indicates that the international cordon keeping coronavirus cases bottled up in China is a leaky one, and it’s likely that the relative handful of global cases reported so far are undercounted. If true, that will lead to widespread illness internationally, including in the U.S.

Studying the mumps virus genomes in 2016 and 2017 filled in gaps about how the disease was spreading in Massachusetts and elsewhere in the U.S.

New technology helps dissect how the brain ignores or acts on information

Though no expert coder, Max Weiss ’20, a government concentrator uses bots to show an agency its website vulnerability.